Firazyr and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Firazyr (icatibant acetate) and Klor-con (potassium chloride). Common drug interactions include hereditary angioedema among females.

The phase IV clinical study analyzes what interactions people have when they take Firazyr and Klor-con. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Firazyr?

Firazyr has active ingredients of icatibant acetate. eHealthMe is studying from 5,650 Firazyr users. Check the latest studies of Firazyr.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.



On Jul, 14, 2026

30 people who take Firazyr and Klor-con together, and have interactions are studied.

Firazyr and Klor-con drug interactions.

What are the common drug interactions of Firazyr and Klor-Con, by gender? *:

female:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Depression
  3. Asthenia (weakness)
  4. Dyspnoea (difficult or laboured respiration)
  5. Burning sensation
  6. Eye disorder
  7. Pruritus allergic (severe allergic itching of the skin)
  8. Venous injury
  9. Venous thrombosis (blood clot (thrombus) that forms within a vein)
  10. Cardiac infection (an infection of the heart)

male:

n/a

What are the common drug interactions of Firazyr and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Anxiety
  3. Apnoea (suspension of external breathing)
  4. Asthenia (weakness)
  5. Balance disorder
  6. Blindness
  7. Blood pressure systolic increased
  8. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Coma (state of unconsciousness lasting more than six hours)

30-39:

  1. Cardiac infection (an infection of the heart)
  2. Infusion site infection
  3. Cardiac valve vegetation (heart valve abnormal growth)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Depressed mood
  6. Upper respiratory tract infection
  7. Catheter site infection (infection at the site of insertion)
  8. Dehydration (dryness resulting from the removal of water)
  9. Device related infection
  10. Herpes zoster

40-49:

  1. Hereditary angioedema (recurrent episodes of severe swelling)

50-59:

n/a

60+:

  1. Cellulitis (infection under the skin)
  2. Drug ineffective
  3. Erythema (redness of the skin)
  4. Feeling hot
  5. Muscle spasms (muscle contraction)
  6. Pain in extremity
  7. Pigmentation disorder (disturbances of human skin colour)
  8. Pulse pressure increased

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 21 people, 70.00%
  2. Immune System Disorder: 10 people, 33.33%
  3. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 5 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Firazyr and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Firazyr and Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Firazyr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Firazyr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on icatibant acetate and potassium chloride (the active ingredients of Firazyr and Klor-con, respectively), and Firazyr and Klor-con (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: